Plasma and Urine Indoleamine 2,3-Dioxygenase Activity: Promising Biomarkers for Chronic Kidney Disease and Inflammation Status

Plasma and Urine Indoleamine 2,3-Dioxygenase Activity: Promising Biomarkers for Chronic Kidney Disease and Inflammation Status

Hao Hong,1 Suya Zhou,2 Haimin Shi,3 Ming Li3 1Intensive Care Unit, The First Affiliated Hospital of Soochow University, Soochow, People’s Republic of China; 2Laboratory Nephrology, Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai, People’s Republic of China; 3Laboratory Nephr...

Full description

Bibliographic Details
Main Authors:	Hong H, Zhou S, Shi H, Li M
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	Journal of Inflammation Research
Subjects:	tryptophan rate-limiting enzyme inflammatory hs-crp liquid chromatography-mass spectrometry
Online Access:	https://www.dovepress.com/plasma-and-urine-indoleamine-23-dioxygenase-activity-promising-biomark-peer-reviewed-fulltext-article-JIR

Similar Items

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
by: Peng X, et al.
Published: (2022-08-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01)

Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
by: Karl Savonije, et al.
Published: (2023-05-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
by: Camilla Grønkjær Jensen, et al.
Published: (2021-07-01)

Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren’s Syndrome in SATB1-Conditional Knockout Mice
by: Yuriko Tanaka, et al.
Published: (2021-09-01)

Threshold effect and sex characteristics of the relationship between chronic inflammation and BMI
by: Su Liqiang, et al.
Published: (2023-08-01)

<i>Indoleamine 2,3-Dioxygenase 2</i> Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
by: Kento Fujii, et al.
Published: (2020-08-01)

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
by: Jacques C. Mbongue, et al.
Published: (2015-09-01)

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
by: Ute F. Röhrig, et al.
Published: (2022-12-01)

A Multifaceted Role of Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Activity in Aspergillus fumigatus–Host Interactions
by: Tsokyi Choera, et al.
Published: (2018-01-01)

Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer
by: Dyah L. Dewi, et al.
Published: (2017-02-01)

The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus
by: Abram DM, et al.
Published: (2017-07-01)

Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study
by: Luukkainen Annika, et al.
Published: (2011-12-01)

Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease
by: Nóra Török, et al.
Published: (2022-09-01)

Kuqin ameliorates Lipopolysaccharide-induced acute lung injury by regulating indoleamine 2,3-dioxygenase 1 and Akkermansia muciniphila
by: Shihui Xiong, et al.
Published: (2023-02-01)

Assessment of High Sensitivity C.Reactive Protein in male patients with metabolic syndrome and atherosclerosis complications
by: Faris Abdul Kareem Khazaal, et al.
Published: (2012-12-01)

Biomarkers of chronic inflammation and cognitive decline: A prospective observational study
by: Bhavna A. Guduguntla, et al.
Published: (2024-01-01)

Serum indoleamine 2,3-dioxygenase level and diagnostic value in patients with rosacea
by: Merve Sena Odabasi, et al.
Published: (2023-01-01)

High-Sensitivity C-Reactive Protein, Its Change, and Cognitive Function: A National Population-Based Cohort Study
by: Yechuang Wang, et al.
Published: (2023-04-01)

Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
by: Ying Tan, et al.
Published: (2022-11-01)

The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression
by: Hengshu Chen, et al.
Published: (2023-02-01)

Effect of curcumin on inflammatory biomarkers and iron profile in patients with premenstrual syndrome and dysmenorrhea: A randomized controlled trial
by: Amir Talebpour, et al.
Published: (2023-07-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
by: Quan, J, et al.
Published: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
by: Quan, J, et al.
Published: (2008)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
by: Wentao Zhang, et al.
Published: (2023-05-01)

Assessment of early kidney injury caused by asymptomatic bacteriuria in children with type 1 diabetes
by: Gihan M. Bebars, et al.
Published: (2022-11-01)

High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk
by: Wang Chun Kwok, et al.
Published: (2024-02-01)

Interleukin‐6 promotes skeletal muscle catabolism by activating tryptophan–indoleamine 2,3‐dioxygenase 1–kynurenine pathway during intra‐abdominal sepsis
by: Tingbin Xie, et al.
Published: (2023-04-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
by: Röhrig, U, et al.
Published: (2010)

Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells
by: Hani Oweira, et al.
Published: (2022-08-01)

Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
by: Mizue Terai, et al.
Published: (2020-02-01)

Diagnostic biomarkers of acute exacerbation of chronic obstructive pulmonary disease at elderly patients
by: Yakup ARSLAN, et al.
Published: (2019-12-01)

Association between Genetic Variants Linked to Premature Ovarian Insufficiency and Inflammatory Markers: A Cross-Sectional Study
by: Mohammad Reza Mirinezhad, et al.
Published: (2024-04-01)

The association between inflammatory markers and obesity-related factors in Tehranian adults: Tehran lipid and glucose study
by: Bita Faam, et al.
Published: (2014-08-01)

HIGH SENSITIVITY C-REACTIVE PROTEIN SEBAGAI FAKTOR RESIKO INDEPENDEN DIBANDING FAKTOR RESIKO KARDIOVASKULER KLASIK PADA INFARK MIOKARD AKUT
by: Eka Fithra Elfi
Published: (2015-12-01)

Comprehensive behavioral analysis of tryptophan 2,3‐dioxygenase (Tdo2) knockout mice
by: Satoko Hattori, et al.
Published: (2018-06-01)

Identification of Genetic Markers Linked to The Activity of Indoleamine 2,3-Dioxygenase and Kidney Function
by: Hye-Rim Kim, et al.
Published: (2023-04-01)

Significance of Indoleamine 2,3-Dioxygenase Expression in the Immunological Response of Kidney Graft Recipients
by: Krzysztof Wiśnicki, et al.
Published: (2022-09-01)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
by: Ganiyu Olatunbosun Arinola, et al.
Published: (2023-01-01)

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
by: Weirui Li, et al.
Published: (2021-02-01)